Target intelligence / Profile preview

RNA, U6 small nuclear 512, pseudogene (RNU6-512P)

Target
RNU6-512P
Molecular classification
Other, Pseudogene, Small nuclear RNA pseudogene
01

Overview

RNU6-512P is annotated as a pseudogene derived from the U6 small nuclear RNA gene family. The canonical U6 snRNA is a highly conserved, non-coding RNA that participates as a core component of the spliceosome, which mediates pre-mRNA splicing in eukaryotic cells[3][1]. Pseudogenes like RNU6-512P are fragments or copies of U6 snRNA genes found throughout the genome, generally non-functional and not transcribed into active snRNA[5]. While rare pseudogenes may influence regulatory networks or be aberrantly expressed in disease states, there is no evidence that RNU6-512P serves as a biomarker, therapeutic target, or disease modulator. RNU6-512P is not a receptor, enzyme, or functional RNA. Its presence reflects genome evolution and gene duplication events[4][5]. Summary: RNU6-512P is a U6 small nuclear RNA-related pseudogene, not a bona fide therapeutic target, receptor, or molecular drug target. It is not misspelled, but it lacks direct biological or clinical relevance and is correctly described as nonfunctional in this context[5].

Other names
RNA, U6 small nuclear 512, pseudogeneRNU6-512PU6 pseudogene 512
02

Mechanism of action

None known; no drugs target this molecule, nor does it mediate drug action[4][5].

03

Biological functions

None directly attributed; parent U6 snRNA is involved in splicing, but pseudogenes themselves generally lack defined functions[5].
04

Disease associations

None established for RNU6-512P specifically. Some pseudogenes can modulate disease phenotypes indirectly as decoys or regulators, but no evidence links RNU6-512P to disease roles[4][6].
05

Safety considerations

None specific; pseudogenes are not generally associated with safety concerns in therapy[4][5].
06

Interacting drugs

None known; pseudogenes like RNU6-512P do not bind drugs or are not targeted therapeutically[4][5].
07

Biomarkers

None established for RNU6-512P; other pseudogenes sometimes act as biomarkers, but not this specific one[4][6].

Beyond the preview

Go deeper on RNA, U6 small nuclear 512, pseudogene (RNU6-512P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 512, pseudogene (RNU6-512P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call